Key Takeaways
- Greater scientific knowledge and tangible everyday benefits boost public optimism toward breakthrough innovations.
- Humans are instinctively wary of uncertainty; acceptance grows only after deliberate, evidence‑based reflection.
- Openness to innovation varies by age, education, geography, and technology sector—healthcare inspires more confidence, food tech enjoys higher optimism than food‑and‑agri, especially in affluent societies where scarcity is less pressing.
- The 2025 study found the highest neutrality toward food‑and‑agri innovations, indicating that public attitudes are still malleable and can be earned through clear demonstration of benefits.
- A landmark EU regulatory shift (June 17, 2025) now permits cultivation and sale of plants whose genetic changes could arise naturally or via traditional breeding, marking the biggest policy change in nearly three decades.
- The new framework paves the way for climate‑resilient, resource‑efficient crops using tools such as CRISPR, addressing projected EU agricultural losses of up to 66 % from climate change by 2050.
- Real‑world examples like CoverCress™—a gene‑edited cover crop that also yields sustainable aviation biofuel—show how NGTs can deliver simultaneous farmer and environmental benefits.
- Lived experience shapes attitudes; societies with recent memory of scarcity (e.g., parts of China) view technology more optimistically when its daily advantages are visible.
- Innovators must pair scientific advancement with proactive trust‑building: transparent governance, credible expert communication, and demonstrable societal impact are essential for broad acceptance.
Knowledge and Visibility Fuel Optimism
Public sentiment toward breakthrough science is increasingly positive when people can see concrete, everyday advantages and when their understanding of the underlying technology deepens. Research shows that familiarity breeds confidence: the more individuals learn about a new innovation—whether through education, media, or direct experience—the more likely they are to view it favorably. This dynamic is especially evident in fields where benefits are immediate and perceptible, such as medical treatments that alleviate symptoms or digital tools that simplify daily tasks. When the link between innovation and personal welfare is clear, skepticism recedes and enthusiasm rises, laying a foundation for broader societal support.
Human Discomfort with Uncertainty and the Innovation Acceptance Spectrum
Despite growing optimism, humans retain a deep‑seated aversion to uncertainty and risk, a tendency highlighted by Daniel Kahneman in Thinking, Fast and Slow. Our instinctive, fast‑thinking system tends to react negatively to the unfamiliar, reserving more measured, reflective judgment for later, effortful consideration. In an era marked by rapid technological change, shifting cultural norms, and geopolitical flux, we encounter novelty more frequently than ever before. Consequently, reactions to breakthrough innovations span a spectrum: some embrace them with excitement, others greet them with fear, and many fall somewhere in between, weighing potential gains against perceived risks.
Variations Across Demographics, Sectors, and Affluence
The degree of openness to innovation is not uniform; it shifts with age, education, geographic location, and the specific technology in question. Healthcare breakthroughs—such as gene therapies or vaccines—typically elicit higher optimism because they directly address personal health concerns. In contrast, food‑and‑agricultural innovations often meet greater caution, particularly in high‑income countries where food scarcity is not an immediate threat. Interestingly, skepticism tends to be stronger in affluent societies, even though these nations produce the majority of global patents and scientific papers. This paradox underscores that wealth does not automatically translate into trust; rather, perceived relevance and personal experience drive acceptance more than economic status alone.
Insights from the 2025 Study: Neutrality Toward Food‑and‑Agri Innovations
The 2025 research surveyed attitudes toward four emerging technologies and found that neutrality was highest for food‑and‑agriculture‑related applications. This neutral stance signals that many respondents have not yet formed a firm opinion, presenting both a challenge and an opportunity for innovators. It suggests that public acceptance is still to be won and hinges on the ability to demonstrate clear, tangible benefits. When people can see how a new agricultural technology improves yield, reduces environmental impact, or enhances nutrition, their neutral position can shift toward support. Conversely, a lack of visible advantage leaves the door open for skepticism to take root.
Europe’s Regulatory Turning Point: New Framework for NGTs
A pivotal moment arrived on 17 June 2025, when the European Parliament endorsed a novel regulatory framework for plants developed through certain New Genomic Techniques (NGTs). Under this framework, plants whose genetic alterations could have occurred naturally or through conventional breeding may now be cultivated and sold within the EU. While traditional genetically modified organisms (GMOs) remain subject to strict restrictions, this decision represents the most significant shift in European agricultural policy in nearly three decades. The move signals a growing reliance on science‑based evidence among legislators and their constituents, reflecting a willingness to let innovation proceed under transparent, risk‑proportionate rules.
Implications for a Resilient, Sustainable Food System
The EU’s updated regulatory stance opens the door to a wave of agricultural innovations aimed at bolstering resilience, sustainability, and competitiveness. Tools such as CRISPR‑Cas9 enable precise edits that can make crops better withstand climate extremes, resist pests and diseases, and use water and nutrients more efficiently. Given that the European Investment Bank and the European Commission project climate‑related agricultural losses could swell to as much as 66 % by 2050, these advances are not merely optional—they are essential for safeguarding food security. By fostering an environment where scientific breakthroughs can be tested and deployed, the EU positions itself to meet future challenges while reducing the environmental footprint of farming.
Concrete Examples: CoverCress™ and CRISPR‑Enabled Crops
Illustrating the potential of NGTs, the gene‑edited cover crop CoverCress™—developed by a Leaps portfolio company now majority‑owned by Bayer—demonstrates dual utility. Grown between corn and soybean rotations, CoverCress™ functions as a traditional cover crop, improving soil health and preventing erosion, while its seeds can be processed into a sustainable aviation biofuel. This synergy exemplifies how a single innovation can deliver multiple benefits: enhancing farm profitability, reducing reliance on fossil fuels, and lowering greenhouse‑gas emissions. Similar CRISPR‑driven traits—such as drought tolerance in wheat or disease resistance in rice—are advancing through the pipeline, promising to translate scientific insight into measurable field‑level gains.
The Power of Lived Experience: Lessons from China
Attitudes toward technology are shaped not only by abstract knowledge but also by lived experience of its benefits. In recent travels across China—from Beijing’s research institutes to Shenzhen’s biotech hubs—I observed a palpable societal openness to innovation, underpinned by the visible improvements it brings to daily life. In regions where food scarcity remains a recent memory or a present concern, people are more inclined to embrace technologies that promise greater abundance and nutrition. As one baby‑boomer respondent remarked, “Ordinary people just want to have enough to eat and eat well. If they don’t have enough to eat, you cannot talk about anything else. Therefore, people would accept the technology if it helps fill their stomach.” This insight underscores that demonstrating real‑world impact is a potent catalyst for acceptance.
The Innovator’s Responsibility: Building Trust and Demonstrating Impact
For breakthrough science to move from laboratory to field, innovators must shoulder responsibilities that extend beyond the technology itself. Building trust and making progress visible are as crucial as the scientific breakthroughs themselves. At Leaps by Bayer, we view this as a core mandate: to invest in transformative science while actively engaging with society, collaborating to showcase benefits, amplifying credible expert voices, and ensuring transparent governance. The recent EU policy shift is encouraging evidence of a growing willingness to embrace scientific advances—a factor vital for global competitiveness. Innovation is not a zero‑sum game; a stronger Europe, supported by policies that enable both research and application, can unleash exponential impact that reverberates far beyond its borders, delivering sustainable food systems, environmental stewardship, and economic growth for all.